Lpl Financial LLC Personalis, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 150,688 shares of PSNL stock, worth $777,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,688

Previous 191,228 21.2%

Holding current value

$777,550

Previous $223,000 263.23%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$1.19 - $6.34 $48,242 - $257,023	-40,540 Reduced 21.2%	150,688 $810,000
Q2 2024 Aug 07, 2024	SELL	$1.17 - $1.65 $23,166 - $32,670	-19,800 Reduced 9.38%	191,228 $223,000
Q1 2024 May 10, 2024	BUY	$1.15 - $2.19 $20,786 - $39,584	18,075 Added 9.37%	211,028 $314,000
Q4 2023 Feb 14, 2024	SELL	$0.93 - $2.35 $1,102 - $2,787	-1,186 Reduced 0.61%	192,953 $405,000
Q3 2023 Nov 13, 2023	SELL	$1.19 - $2.36 $7,665 - $15,203	-6,442 Reduced 3.21%	194,139 $234,000
Q2 2023 Jul 31, 2023	BUY	$1.8 - $3.19 $30,940 - $54,832	17,189 Added 9.37%	200,581 $377,000
Q1 2023 May 10, 2023	BUY	$2.01 - $4.17 $91,539 - $189,910	45,542 Added 33.04%	183,392 $506,000
Q4 2022 Feb 07, 2023	BUY	$1.78 - $3.64 $103,263 - $211,167	58,013 Added 72.66%	137,850 $272,000
Q3 2022 Nov 14, 2022	BUY	$2.89 - $5.32 $65,363 - $120,322	22,617 Added 39.53%	79,837 $237,000
Q2 2022 Aug 12, 2022	BUY	$3.27 - $8.76 $131,892 - $353,325	40,334 Added 238.86%	57,220 $197,000
Q1 2022 May 16, 2022	BUY	$7.56 - $14.3 $127,658 - $241,469	16,886 New	16,886 $138,000

Others Institutions Holding PSNL

# of Institutions

Shares Held

30M

Call Options Held

27.5K

Put Options Held

85.4K

View Full List

About Personalis, Inc.

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $237M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

More about PSNL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Personalis, Inc. Transaction History